Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 8-K: Current report
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed an 8-K on Oct 26, 2026 reporting termination of a material agreement (Item 1.02), with exhibits (Item 9.01).
Key facts
- Item 1.02 · Termination of a material agreement
- Item 9.01 · Financial statements and exhibits
More SUPN filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Oct 19, 2026
- 8-K
Filed Oct 15, 2026
- 425
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.